Tesla
TSLA
Strategy
MSTR
Vale SA
VALE
4
Alphabet-C
GOOG
5
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
CGEN Compugen
- 1.4600
- 0.00000.00%
Trading Apr 1 11:13 ET
136.53MMarket Cap-9.13P/E (TTM)
1.4700High1.4200Low78.74KVolume1.4700Open1.4600Pre Close113.50KTurnover0.09%Turnover RatioLossP/E (Static)93.51MShares2.660052wk High2.49P/B133.74MFloat Cap1.350052wk Low--Dividend TTM91.60MShs Float19.9000Historical High--Div YieldTTM3.43%Amplitude0.3400Historical Low1.4410Avg Price1Lot Size
About Compugen Company
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Company Profile
SymbolCGEN
Company NameCompugen
Listing DateAug 11, 2000
Issue Price10.00
Founded1993
CEODr. Anat Cohen-Dayag, PhD
MarketNASDAQ
Employees74
Fiscal Year Ends12-31
AddressAzrieli Center,26 Harokmim Street,Building D
CityHolon
ProvinceTel Aviv
CountryIsrael
Zip Code58858
Phone972-3-765-8585
Websitehttp://www.cgen.com
Company Executives
- Name
- Position
- Salary
- Dr. Anat Cohen-Dayag, PhD
- Director, President and Chief Executive Officer
- 1.24M
- David Silberman
- Chief Financial Officer
- --
- Dr. Michelle Mahler, M.D.
- Chief Medical Officer
- 592.99K
- Dr. Eran Ophir, PhD
- Chief Scientific Officer
- 478.22K
- Dr. Zurit Levine,PhD
- Senior Vice President, Technology Innovation
- 461.80K
- Dr. Yaron Turpaz, PhD
- Senior Vice President and Senior Advisor, Computational Discovery
- --
- Dr. Pierre Ferre, Pd.D
- Senior Vice President, Preclinical Development and Corporate Operations
- 604.00K
- Paul J. Sekhri
- Chairman of the Board
- --
- Sanford S. Zweifach
- Independent Director
- --
- Gilead Halevy
- Independent Director
- --
- Eran Perry
- Independent Director
- --
- Dr. Mathias Hukkelhoven, PhD
- Independent Director
- --
- Dr. Kinneret Livnat Savitzky, PhD
- Independent Director
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025